Nelsen Robert
Prime Medicine, Inc. · Director, 10% Owner
Nelsen Robert is listed in filings as Director, 10% Owner at Prime Medicine, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including purchase activity. Recent filings connect the profile to Prime Medicine, Inc. (PRME), Sana Biotechnology, Inc. (SANA), and Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Jun 14, 2024 to Jun 8, 2026. Reported amounts are shown as $229.5K to $345.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $10M3M shares | BuyAug 1, 2025 | $3.30 | $3.22 |